D, P., M, S., K, K., & Z, F. (2010). Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity. International journal of cancer, 126(6), 1428. https://doi.org/10.1002/ijc.24888
Chicago Style (17th ed.) CitationD, Pilzer, Saar M, Koya K, and Fishelson Z. "Mortalin Inhibitors Sensitize K562 Leukemia Cells to Complement-dependent Cytotoxicity." International Journal of Cancer 126, no. 6 (2010): 1428. https://doi.org/10.1002/ijc.24888.
MLA (9th ed.) CitationD, Pilzer, et al. "Mortalin Inhibitors Sensitize K562 Leukemia Cells to Complement-dependent Cytotoxicity." International Journal of Cancer, vol. 126, no. 6, 2010, p. 1428, https://doi.org/10.1002/ijc.24888.
Warning: These citations may not always be 100% accurate.